"L’Institut du Cancer de Montpellier (ICM) est le centre de référence en Occitanie-Est, reconnu au niveau national pour son expertise et son innovation dans la prise en charge et le traitement des patients atteints de cancers : cancer du sein, cancers digestifs (colon, rectum, pancréas…), cancers gynécologiques (col de l’utérus, ovaires…), cancer de la prostate, cancer du poumon, sarcomes, cancer ORL... La prise en charge et l’accompagnement des patients atteints de cancer à Montpellier et dans toute la région est assurée par des équipes médicales pluridisciplinaires spécialisées. Il regroupe des unités de soins, de prévention, de recherche clinique, translationnelle et fondamentale en cancérologie. L’ICM fait partie du réseau UNICANCER."

During the past decade, Centre Val d'Aurelle conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Val d'Aurelle" #1 collaborator was "UNICANCER" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centre Val d'Aurelle" are "Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centre Val d'Aurelle" in a lesser frequency.

Most popular intervention types in "Centre Val d'Aurelle" are "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Letrozole" (1 trials), "PD-0332991" (1 trials), "Placebo" (1 trials), "boost" (1 trials) and "high dose boost" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Val d'Aurelle" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Val d'Aurelle". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centre Val d'Aurelle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre Val d'Aurelle, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".